- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 07.02. | Impact of proposed US tariffs on pharmaceutical FDI in Canada, Mexico, China and Europe | ||
| 07.02. | Sanofi increases ownership stake partaking in pharma buyback trend | ||
| 07.02. | Alumis and Acelyrin sign merger agreement | ||
| 07.02. | 43rd Annual JP Morgan Healthcare Conference 2025 OR | ||
| 07.02. | Genentech eyes lupus market for Gazyva with positive Phase III data readout | ||
| 07.02. | How AI is streamlining cell and gene therapy manufacturing | ||
| 07.02. | Relmada acquires Tourette's therapy rights from Asarina | ||
| 07.02. | Treating alcohol addiction: filling the medication gap | ||
| 07.02. | Dr Reddy's and Shanghai Henlius sign agreement for HLX15 | ||
| 06.02. | AstraZeneca's shares rise as it addresses China investigation | ||
| 06.02. | Novo Nordisk plans new study for CagriSema, targets 2026 submission | ||
| 06.02. | FDA grants orphan drug status to Arbor Biotechnologies' PH1 | ||
| 06.02. | Supernus wins FDA approval for Parkinson's pump on fourth try | ||
| 06.02. | Tripartite MoU signed for mRNA production platform in Egypt | ||
| 06.02. | USPTO grants patent to Vistagen's neuropathic pain treatment | ||
| 05.02. | X-Elio partners with pharmaceutical programme for 10-year solar PPA | ||
| 05.02. | Valneva's chikungunya vaccine wins UK approval | ||
| 05.02. | Supply chains and AI take precedence at European clinical trial meeting | ||
| 05.02. | GSK stays optimistic on vaccines amidst US and China woes | ||
| 05.02. | Astellas seeks conditional approval for GA treatment in Japan | ||
| 05.02. | Trump's tariffs could strain medicine supply and drive drug costs | ||
| 05.02. | Driving innovation in respiratory health: Areteia's 2025 milestones and future goals | ||
| 05.02. | MedPharm appoints Bill Humphries as new CEO | ||
| 05.02. | Jabil acquires CDMO Pii to support drug development customers | ||
| 05.02. | Radiopharmaceutical deals drive sector growth despite supply crisis |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
